What is Ketryx?
Ketryx is at the forefront of revolutionizing the product lifecycle for life science teams, enabling them to deliver safer products more rapidly. The company's AI-powered compliance platform is already trusted by three of the top five global medical device manufacturers. It seamlessly integrates with existing tools, automating documentation, establishing comprehensive traceability, and accelerating release cycles without disrupting current workflows. This approach positions Ketryx as a critical enabler for innovation and regulatory adherence in a highly complex industry.
How much funding has Ketryx raised?
Ketryx has raised a total of $89.1M across 3 funding rounds:
Series A
$14M
Series B
$39M
Private Equity
$36.1M
Series A (2023): $14M with participation from Ubiquity Ventures, Lightspeed Venture Partners, and E14 Fund
Series B (2025): $39M led by Lightspeed Venture Partners, Ubiquity Ventures, MIT, and Transformation Capital
Private Equity (2025): $36.1M, investors not publicly disclosed
Key Investors in Ketryx
Ubiquity Ventures
Ubiquity Ventures is a seed-stage venture capital firm focused on 'software beyond the screen' startups, investing in companies that leverage smart hardware and machine intelligence to solve real-world physical problems through software.
Lightspeed Venture Partners
Lightspeed Venture Partners is a global, multistage venture capital firm that invests in early and growth-stage technology companies across enterprise software, consumer, fintech, and infrastructure sectors.
Transformation Capital
Transformation Capital is a growth equity fund based in Boston, Massachusetts, with a dedicated focus on innovative healthcare IT and services companies.
What's next for Ketryx?
The substantial enterprise-level capital infusion signifies Ketryx's transition into a scaling phase, likely Series B or beyond, given the context. This strategic backing will undoubtedly fuel further development of its AI-driven compliance platform, expand its market reach, and enhance its capabilities to serve an increasingly demanding life science sector. The company is poised to solidify its position as an indispensable partner for medical device manufacturers and other life science entities navigating stringent regulatory landscapes.
See full Ketryx company page
